Yi Larson's Net Worth
$2.08 Million
Who is Yi Larson?
Yi Larson has an estimated net worth of $2.08 Million. This is based on reported shares across multiple companies, which include Turning Point Therapeutics, Inc., LianBio, Olema Pharmaceuticals, Inc., and RayzeBio, Inc..
SEC CIK
Yi Larson's CIK is 0001785987
Past Insider Trading and Trends
2021 was Yi Larson's most active year for acquiring shares with 9 total transactions. Yi Larson's most active month to acquire stocks was the month of May. 2021 was Yi Larson's most active year for disposing of shares, totalling 11 transactions. Yi Larson's most active month to dispose stocks was the month of January. 2021 saw Yi Larson paying a total of $1,620,900.00 for 337,739 shares, this is the most they've acquired in one year. In 2021 Yi Larson cashed out on 60,000 shares for a total of $3,801,917.69, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Turning Point Therapeutics, Inc. No price found
EVP & Chief Financial OfficerYi Larson owns 7,321 units of Common Stock.acquired a total of 36,839 shares in Turning Point Therapeutics, Inc. at a cost of $1,720,890.00, Yi also disposed a total of 30,000 shares of Turning Point Therapeutics, Inc. equalling to $3,801,917.69.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +170.75% | 4.62K |
—
|
—
| 7.32K |
Feb 8
| |||
Form 4
|
—
|
0
|
$90.38 | -$2,181,017.69 | 2.7K |
Scheduled
|
Feb 1 - Feb 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
∞
| 2.22K |
$45.00 | $99,990.00 | 2.22K |
Sep 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LianBio (LIAN) No price found
Chief Financial OfficerYi Larson owns 325,901 units of Ordinary Shares. From 2021 to 2023 Yi Larson acquired a total of 325,901 shares in LianBio.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 325.9K |
—
|
—
| 325.9K |
Mar 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Olema Pharmaceuticals, Inc. (OLMA) Snapshot price: $11.85
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RayzeBio, Inc. (RYZB) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||